
Our Cells
RESTEM has developed world-leading cellular therapeutics to evolve innovative allogeneic cellular medicines to treat complex inflammatory diseases.
More info
COVID19 Response
RESTEM is committed to the development of technologies that ensure our world’s health and wellbeing.
Presently, we are in clinical studies for COVID19 presenting solutions for unmet needs.

Clinical Trials
We are proud donors of cGMP stem cells for clinical studies. Presently, moving forward with clinical studies on Autoimmune diseases, COVID19, Duchenne Muscular Dystrophy and Heart Failure secondary issues following left ventricular assisted.
More info